-
2024-518893-15-00
5
2025-07-29
Chronic lymphotic leukemia and Small Lymphocytic lymphoma
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2024-517991-39-00
5
2025-07-22
Asthma
-
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2024-513869-39-00
5
2025-06-27
Obstructive Cardiomyopathy, Hypertrophic
-
2024-514539-67-00
4
2025-06-27
Systemic Sclerosis
-
2024-513111-27-00
5
2025-06-26
Psoriatic Arthritis
-
2024-515796-35-00
4
2025-06-26
Heart Failure with Preserved Ejection Fraction and Left Ventricular Hy
-
2024-515797-27-00
4
2025-06-25
Heart Failure with Reduced/Mildly Reducede Ejection Fraction and Left
-
2024-519318-30-00
1
2025-06-25
non-Hodgkin Lymphomas
Subtypes:
DLBCL - ORPHA: 544
Agressive B-cell
-
2024-519248-34-00
4
2025-06-17
Cervical Dystonia
-
2024-513112-99-00
5
2025-06-13
Active Psoriatic Arthritis Stratified by Prior Biologic Use
-
2024-515764-31-00
10
2025-06-13
Non-small cell lung cancer
-
2023-505218-68-00
4
2025-06-12
Moderate-Severe Atopic Dermatitis
-
2024-515698-85-00
5
2025-06-12
Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
2023-509547-27-00
5
2025-05-22
Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-517513-32-00
5
2025-05-16
Sjögren’s Syndrome
-
2023-506327-29-00
5
2025-05-14
Non-Small Cell Lung Cancer
-
2024-515593-27-00
5
2025-05-08
relapsed or refractory mantle cell lymphoma (R/R MCL)
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-517284-23-00
5
2025-04-23
Active Psoriatic Arthritis
-
2024-513053-69-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)